Eagle Pharmaceuticals EGRX

$ 2.14 -39.89%

Quarterly report 2023-Q2
added 08-08-2023

Eagle Pharmaceuticals Depreciation & Amortization 2011-2024 | EGRX

Annual Depreciation & Amortization Eagle Pharmaceuticals

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
646 K	764 K	872 K	972 K	1.16 M	932 K	641 K	112 K	104 K	135 K	240 K	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.16 M	104 K	598 K

Quarterly Depreciation & Amortization Eagle Pharmaceuticals

2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
100 K	100 K	-	200 K	200 K	200 K	-	200 K	200 K	200 K	-	196 K	209 K	251 K	-	241 K	241 K	242 K	-	918 K	683 K	341 K	-	657 K	432 K	196 K	-	461 K	296 K	140 K	-	31 K	22 K	12 K	13 K	73 K	51 K	29 K	31 K	105 K	78.5 K	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
918 K	12 K	223 K